Compound ID | 967

Update compound information

J110441

Class: Beta-lactamase inhibitor (methylcarbapenem)

Spectrum of activity: Gram-positive & Gram-negative
Combined with other compounds: Tested pairing with imipenem showed for IMP-1 producing clinical isolateds reduced MICs
Institute where first reported: Banyu Pharmaceutical Co. Ltd.( Merck & Co, USA)
Year first mentioned: 1999
Highest developmental phase: Preclinical
Development status: Inactive
Chemical structure(s):
Click here for structure editor
Molecular weight: 375.46
Iso. SMILES: C[C@@H]1[C@@H]2[C@H](C(=O)N2C(=C1SC3=CC4=CC=CC=C4S3)C(=O)O)[C@@H](C)O
InChI Key: MARAOMYICBQCLN-HFOBELJZSA-N
Can. SMILES: C[C@@H]1[C@@H]2[C@@H]([C@@H](C)O)C(=O)N2C(=C1SC3=CC4=C(C=CC=C4)S3)C(=O)O
InChI: InChI=1S/C18H17NO4S2/c1-8-14-13(9(2)20)17(21)19(14)15(18(22)23)16(8)25-12-7-10-5-3-4-6-11(10)24-12/h3-9,13-14,20H,1-2H3,(H,22,23)/t8-,9-,13-,14-/m1/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/9822198
Citations:
  • https://journals.asm.org/doi/full/10.1128/AAC.43.10.2497

  • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.